|

CTX-8371 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Compass Therapeutics1

Indications

  • Malignant Melanoma1
  • Hodgkin Lymphoma1
  • Triple Negative Breast Cancer1
  • Head and Neck Squamous Cell Carcinoma1
  • Lung Cancer1

Margate, Florida1 trial

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

D&H Cancer Research Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.